OrthoSensor says it closed a Series C funding round worth $19 million for its Verasense knee implant technology.
OrthoSensor said today that it closed out a $19 million Series C round it plans to use to commercialize its Verasense knee implant technology.
Dania Beach, Fla.-based OrthoSensor said Bridger Healthcare and the Tullis Growth Fund participated in the round.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1IlaRcH
Cap comentari:
Publica un comentari a l'entrada